These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 16091084)

  • 21. Spasticity and strength changes as a function of selective dorsal rhizotomy.
    Engsberg JR; Olree KS; Ross SA; Park TS
    J Neurosurg; 1998 Jun; 88(6):1020-6. PubMed ID: 9609297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Measurement of the silent period after Hoffmann's reaction as an indicator of the effect of exercise therapy on muscle spasticity in children with cerebral palsy].
    Nowotny J; Krauze M; Moskała H; Adowska E; Marek J
    Pol Tyg Lek; 1980 Nov; 35(45):1741-3. PubMed ID: 7220374
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of prolonged standing on gait in children with spastic cerebral palsy.
    Salem Y; Lovelace-Chandler V; Zabel RJ; McMillan AG
    Phys Occup Ther Pediatr; 2010 Feb; 30(1):54-65. PubMed ID: 20170432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of gait and isokinetic movements for evaluation of antispastic drugs or physical therapies.
    Knutsson E
    Adv Neurol; 1983; 39():1013-34. PubMed ID: 6229155
    [No Abstract]   [Full Text] [Related]  

  • 25. Managing spastic hypertonia in children with cerebral palsy via repetitive passive knee movements.
    Cheng HY; Ju YY; Chen CL; Wong MK
    J Rehabil Med; 2012 Mar; 44(3):235-40. PubMed ID: 22366894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationships between spasticity, strength, gait, and the GMFM-66 in persons with spastic diplegia cerebral palsy.
    Ross SA; Engsberg JR
    Arch Phys Med Rehabil; 2007 Sep; 88(9):1114-20. PubMed ID: 17826455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of modified Ashworth scale and Hoffmann reflex in study of spasticity.
    Kohan AH; Abootalebi S; Khoshnevisan A; Rahgozar M
    Acta Med Iran; 2010; 48(3):154-7. PubMed ID: 21137650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of spasticity in cerebral palsy: dependence of catch angle on velocity.
    Wu YN; Ren Y; Goldsmith A; Gaebler D; Liu SQ; Zhang LQ
    Dev Med Child Neurol; 2010 Jun; 52(6):563-9. PubMed ID: 20132137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Roles of reflex activity and co-contraction during assessments of spasticity of the knee flexor and knee extensor muscles in children with cerebral palsy and different functional levels.
    Pierce SR; Barbe MF; Barr AE; Shewokis PA; Lauer RT
    Phys Ther; 2008 Oct; 88(10):1124-34. PubMed ID: 18703677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in kinematic parameters and plantarflexor reflex responses between manual (Ashworth) and isokinetic mobilisations in spasticity assessment.
    Rabita G; Dupont L; Thevenon A; Lensel-Corbeil G; Pérot C; Vanvelcenaher J
    Clin Neurophysiol; 2005 Jan; 116(1):93-100. PubMed ID: 15589188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effect of botulinum toxin (A) in the management of calf spasticity in children with diplegic cerebral palsy.
    Hawamdeh ZM; Ibrahim AI; Al-Qudah AA
    Eura Medicophys; 2007 Sep; 43(3):311-8. PubMed ID: 17268388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of vibration therapy on spasticity and motor function in children with cerebral palsy: a randomized controlled trial.
    Katusic A; Alimovic S; Mejaski-Bosnjak V
    NeuroRehabilitation; 2013; 32(1):1-8. PubMed ID: 23422453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Motor endplate-targeted botulinum toxin injections of the gracilis muscle in children with cerebral palsy.
    Van Campenhout A; Bar-On L; Desloovere K; Huenaerts C; Molenaers G
    Dev Med Child Neurol; 2015 May; 57(5):476-83. PubMed ID: 25557985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of clinical spasticity assessment in cerebral palsy using inertial sensors.
    van den Noort JC; Scholtes VA; Harlaar J
    Gait Posture; 2009 Aug; 30(2):138-43. PubMed ID: 19525113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electrophysiologic assessment of spasticity in children using H-reflex.
    Tekgül H; Polat M; Tosun A; Serdaroğlu G; Gökben S
    Turk J Pediatr; 2013; 55(5):519-23. PubMed ID: 24382533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of multilevel botulinum toxin a and comprehensive rehabilitation on gait in cerebral palsy.
    Scholtes VA; Dallmeijer AJ; Knol DL; Speth LA; Maathuis CG; Jongerius PH; Becher JG
    Pediatr Neurol; 2007 Jan; 36(1):30-9. PubMed ID: 17162194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Botulinum toxin type A in the treatment plan for cerebral palsy].
    Strobl W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():30-5. PubMed ID: 15506050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relation between spasticity and muscle behavior during the swing phase of gait in children with cerebral palsy.
    Bar-On L; Molenaers G; Aertbeliën E; Monari D; Feys H; Desloovere K
    Res Dev Disabil; 2014 Dec; 35(12):3354-64. PubMed ID: 25240217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of spasticity with age in a total population of children with cerebral palsy.
    Hägglund G; Wagner P
    BMC Musculoskelet Disord; 2008 Nov; 9():150. PubMed ID: 18990204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.